The reasons behind the overactivation of Nrf2 in cancer cells are not well clear, although several potential mechanisms have been proposed such as Keap1 mutation that will accumulate Nrf2 in the nucleus and preventing also its re-uptake (No et al., 2014). The gene discussed is NFE2L2; the disease is cancer.